The S&P 500 could have a total return of as much as 11 percent next year, including nearly a 2 percent dividend, analyst David Darst tells CNBC.» Read More
Rob Nail, Singularity University CEO, discusses the impact of exponential technologies on finance. Nail says every industry is being impacted by technologies powered by information layers.
Discussing who is vulnerable amid multiple investigations into Herbalife, the company's aggressive buyback, with Bill Ackman, founder and CEO of Pershing Square Capital Management.
Discussing Tyson's win to buy Hillshire Brands, and M&A in the food industry, with B&G Foods CEO David Wenner.
Bill Ackman, founder and CEO of Pershing Square Capital Management, answers why he thinks Valeant's potential takeover of Allergan is beneficial, and the 'unprecedented' terms in the bid.
Discussing "very little" food price pressure for his business, and how the acquisition of brands happens in the food industry, with B&G Foods CEO David Wenner.
CNBC's Steve Liesman provides insight to controversy about jobs data.
Ohio Sen. Rob Portman (R), provides perspective on lower tax rates around the world compared to the U.S., saying the international taxation system needs to be changed.
Merck announced it will buy biotechnology company Idenix for $24.50 per share in cash, with the "Squawk Box" crew.
Discussing the evolution of big pharmaceutical companies, and Valeant's old and new R&D model, with Michael Porter, Harvard Business School professor. Bill Ackman, founder and CEO of Pershing Square Capital Management, weighs in.
Bill Ackman, founder and CEO of Pershing Square Capital Management, discusses James Chanos' short thesis of Valeant Pharmaceuticals.
Now that they've made-up, Bill Ackman tells CNBC he's trying to get Carl Icahn to sell Herbalife.
Bill Ackman, founder and CEO of Pershing Square Capital Management, addresses what a bad rollup looks like in business, and defends why Valeant Pharmaceuticals is "not just a rollup."
The Brooklyn Brewery founder Steve Hindy, discusses the likelihood he'd sell his brewing company to one of the larger beer companies.
The Brooklyn Brewery founder Steve Hindy, says it seems important Europe gets its beer delivered which has been brewed in Brooklyn, and its potential plan to brew in Asia and grow internationally.
Drew Matus, UBS senior economist, questions what jobs data signals about the U.S. economy. Barbara Reinhard, Credit Suisse, discusses the potential direction of U.S. interest rates.
Discussing the health of the economies in Europe amid a low rate environment, and what could help boost the U.S. economy, with Mark Grant of Southwest Securities. He does not see the 10-year Treasury getting to 3 percent for years.
Former Federal Housing Administration head David Stevens tells CNBC that student loan debt and the jobs outlook are holding back housing.
Last month's employment report can be classified in one way: steady as she goes. The data were basically in-line.
Christopher Kay, NYRA president & CEO, discusses the business of horse racing, as California Chrome looks to end a 36-year drought of Triple Crown winners.
Even though the jobs number appears to be better-than-expected, don't take your cues from the bonds, says CNBC's Jim Cramer, sharing his perspective on Friday's employment report. Also Cramer explains how corporate taxes are impacting wage earners.
Get the best of CNBC in your inbox